SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

NCT03614949 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer
Cervical Cancer Recurrent
Cervical Cancer Metastatic

Interventions

RADIATION: Stereotactic body radiation therapy (SBRT)
DRUG: Atezolizumab

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]